Spine technology company Alphatec saw 27% revenue growth in the first quarter of 2024, reaching $138 million.
It also saw a 30% growth in surgical revenue, with a 23% increase in surgical volume and 6% increase in average revenue per procedure, according to a May 7 Alphatec news release.
During the first quarter, the company hosted 150 surgeon training engagements, fueled a 21% growth in surgeon adoption and utilization, expanded in major markets, grew by 28% in established territories and deployed approximately $60 million of revenue-generating assets to capitalize on market opportunity.
The company now expects total revenue to grow 25% to $601 million for the full fiscal year, compared to the previous expectation of $595 million.